Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OMEPRAZOLE, with a corresponding US DMF Number 15024.
Remarkably, this DMF maintains an Active status since its submission on August 25, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 30, 2013, and payment made on January 10, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II